Cerenome Inc. (CNSY)
NASDAQ
Delayed Data
Aug 7, 2026, 01:30 PM
Day's Range
3.7752 wk Range
2.90Overview - CNSY - Cerenome Inc.
Key Statistics
Valuation
Enterprise Value
11.97M
P/E (Trailing)
0.17
P/E (Forward)
-1.59
PEG Ratio
-1.59
Price / Sales (TTM)
5.08
Price / Book
2.19
EV / EBITDA
-0.64
Profitability
Profit Margin
-230.23%
Operating Margin
-692.51%
Return on Assets
-73.81%
Return on Equity
-560.21%
Ownership
Shares Outstanding
6.86M
Float
6.45M
Short % of Shares Outstanding
10.35%
Held by Insiders
1.83%
Held by Institutions
15.01%
Price stats
Beta
1.41
50-Day Avg
4.29
200-Day Avg
8.01
Dividends
Payout Ratio
0.00%
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - CNSY - Cerenome Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- CNSYNASDAQCerenome, Inc.26.36MMarket Cap-275.49%52-week change0.18P/E (Trailing)-230.23%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - CNSY - Cerenome Inc.
About
Cerenome, Inc. is a central nervous system oncology company focused on improving detection and treatment of cancers affecting the brain and spinal cord. The company operates an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence-driven data analytics to address…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
